Alex Moreau

Alex Moreau is a senior leader at Champions Oncology, driving strategic partnerships and platform-enabled innovation in oncology target discovery and translational biomarker research. With over a decade of experience at the intersection of science and technology, he has led and supported oncology drug discovery programs across world-leading CROs and advised biotechnology companies in gene editing and next-generation sequencing. He holds a PhD in Neuroscience from Université Paris-Saclay (France) and completed postdoctoral research in experimental gene therapy at University College London (UK).